NYSE:CDAYCeridian HCM Stock Price, Forecast & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CDAY stock has increased by 50.1% and is now trading at $84.99. View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) posted its earnings results on Wednesday, May, 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.12 by $0.03. The business had revenue of $222.70 million for the quarter, compared to analyst estimates of $218.42 million. Ceridian HCM had a net margin of 9.03% and a return on equity of 1.80%. The business's revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.14 EPS. View Ceridian HCM's earnings history.

15 analysts have issued twelve-month target prices for Ceridian HCM's shares. Their forecasts range from $45.00 to $85.00. On average, they expect Ceridian HCM's stock price to reach $66.82 in the next year. This suggests that the stock has a possible downside of 21.4%. View analysts' price targets for Ceridian HCM.

News articles about CDAY stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ceridian HCM earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Ceridian HCM.

Ceridian HCM saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 7,780,000 shares, a drop of 21.3% from the June 15th total of 9,890,000 shares. Based on an average daily volume of 1,420,000 shares, the short-interest ratio is presently 5.5 days. Approximately 6.9% of the shares of the stock are short sold. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Dassault Systemes (DASTY), Electronic Arts (EA), Veeva Systems (VEEV), Docusign (DOCU), Twilio (TWLO), Splunk (SPLK), Synopsys (SNPS), Cadence Design Systems (CDNS), Datadog (DDOG), Okta (OKTA), ANSYS (ANSS), Atlassian (TEAM), Crowdstrike (CRWD), Coupa Software (COUP) and Paycom Software (PAYC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Paycom Software (PAYC), Advanced Micro Devices (AMD), Costco Wholesale (COST), Alteryx (AYX), Shopify (SHOP) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by many different institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.01%) and Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching, and Thomas H Lee Advisors, Llc. View insider buying and selling activity for Ceridian HCM.

CDAY stock was purchased by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $84.99.

Ceridian HCM has a market capitalization of $12.33 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]